Article (Scientific journals)
Fièvre méditerranéenne familiale
Leclercq, P.; Hermesse, A.; Malaise, Michel
2004In Revue Médicale de Liège, 59 (5), p. 320-325
Peer reviewed
 

Files


Full Text
Malaise_2004_RevMedLiege_320-325.pdf
Publisher postprint (455.56 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Amyloidosis; Cytoskeletal Proteins; Gout Suppressants; Proteins; marenostrin; Colchicine
Abstract :
[en] Familial Mediterranean Fever (FMF) is an hereditary disease that especially affects people living around the Mediterranean sea. It is characterized by recurring fever and abdominal pain, eventually associated with localised pleuritis, synovitis or skin inflammation. The most serious complication is amyloidosis, which can lead to terminal renal failure. The attacks and complications can be avoided by life long administration of colchicine. Two independent French and American teams discovered the gene responsible for the disease in 1997. It encodes for a protein named pyrin/marenostrin involved in the homeostasis the inflammatory mechanisms. The main mutations have been identified and are henceforth accessible for molecular screening.
Disciplines :
Rheumatology
Author, co-author :
Leclercq, P.
Hermesse, A.
Malaise, Michel ;  Université de Liège - ULiège > Département des sciences cliniques > Rhumatologie
Language :
French
Title :
Fièvre méditerranéenne familiale
Alternative titles :
[en] Familial Mediterranean fever
Publication date :
2004
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Hopital de Baviere, Liège, Belgium
Volume :
59
Issue :
5
Pages :
320-325
Peer reviewed :
Peer reviewed
Additional URL :
Available on ORBi :
since 19 September 2010

Statistics


Number of views
76 (3 by ULiège)
Number of downloads
367 (5 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0

Bibliography


Similar publications



Contact ORBi